Mondrian Investment Partners LTD Takeda Pharmaceutical CO LTD Transaction History
Mondrian Investment Partners LTD
- $5.77 Billion
- Q2 2024
A detailed history of Mondrian Investment Partners LTD transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Mondrian Investment Partners LTD holds 7,738,748 shares of TAK stock, worth $107 Million. This represents 1.74% of its overall portfolio holdings.
Number of Shares
7,738,748
Previous 12,079,962
35.94%
Holding current value
$107 Million
Previous $168 Million
40.32%
% of portfolio
1.74%
Previous 2.47%
Shares
18 transactions
Others Institutions Holding TAK
# of Institutions
320Shares Held
70.4MCall Options Held
939KPut Options Held
233K-
Capital Research Global Investors Los Angeles, CA13.1MShares$182 Million0.04% of portfolio
-
Morgan Stanley New York, NY4.99MShares$69.1 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.35MShares$60.2 Million0.03% of portfolio
-
Goldman Sachs Group Inc New York, NY3.72MShares$51.5 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.95MShares$40.9 Million0.07% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $43.1B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...